当前位置:首页 > 关于我们 > 创投导师 > 何欣

何欣 | He Xin


26.jpg

何欣

普林斯顿大学化学硕士 

美国耶鲁大学免疫生物博士

Howard Hughes Medical Institute研究员

汇鼎投资管理合伙人

曾任鼎晖投资高级合伙人,主导在医药、器械和医疗服务行业的投资,投资和管理近20个项目。曾任汇丰银行私募股权医药投资的全权合作伙伴;

主导投资的企业包括正海生物、斯丹赛ICT、南新药业、新世纪医疗、康宁医院、Mabpharm、诺一迈尔、诺安百特、科望等多个业内领军企业。


He Xin

 Master of Chemistry, Princeton University

 PhD in Immunobiology, Yale University, USA

 Researcher of Howard Hughes Medical Institute

 Management Partner of HD Capital

 She was the senior partner of CDH Investments, leading investment in medicine, medical devices and medical services for nearly 20 projects. Has been a partner in private equity investments in medicine of HSBC;

Led the investment of enterprises including Zhenghai Bio-tech,ICT, NUCIEN, New Century Healthcare, Kangning Hospital Group, Mabpharm、 NEO MODULUS, NO-ANTIBIOTICS, Elpiscience and so on.


0.186500s